California Oncology Weekly Newsletter 3.28.17

This Weekly’s Hot Topics

  • Need HELP with your health plan? (DMCS News)
  • The NIH is working towards a nationwide single IRB model. (National News)
  • March 31st is deadline to submit 2016 EHR data via QRDA. (CMS News)

The House Republican plan to repeal and replace the Affordable Care Act. CMA expressed serious concerns about the floor version of the AHCA and urged the Republican leadership to rework the bill so that millions of Californians did not lose insurance coverage, it increased Medi-Cal payment rates to improve access to care, and there were adequate tax credits to make insurance affordable for low-moderate income families. For more information click here and go to California News.

As the California Dialogue On Cancer (CDOC) continues to strengthen its Policy, Systems, and Environmental (PSE) change efforts as a means to effectively reduce the burden of cancer, the CDOC would like to hear from you on what your PSE needs may be. CDOC has created a short survey to help them gauge interest in learning more about, and implementing PSE interventions in your work.  For more information click here and go to California News.

Multi-Factor Authentication Required on Noridian Medicare Portal – Beginning April 1, 2017.  Beginning April 1, 2017 the Noridian Medicare Portal (NMP) will require a multi-factor authentication (MFA) process for users each time you need to log into NMP. MFA adds a second layer of security to your NMP account. For more information click here and go to Noridian News.

The National Institutes of Health is leading policy and programmatic initiatives to streamline and accelerate the overly cumbersome process of developing and conducting multisite clinical trials. The Clinical & Translational Science Awards (CTSA) Program paves the way for nationwide single IRB model. For more information click here and go to National News.

Physicians and Providers now have until, THIS FRIDAY, March 31 to submit their 2016 EHR data via QRDA. CMS has extended the data submission deadline for the EHR reporting mechanism of the 2016 Quality Reporting Document Architecture (QRDA) for the Physician Quality Reporting System (PQRS) program. Individual eligible professionals (EPs), PQRS group practices, qualified clinical registries (QCDRs), and qualified EHR data submission vendors (DSVs) are included in this extension. For more information click here and go to CMS News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

March 28, 2017.

 

This Weekly’s Hot Topics

  • Oncology Care Model & USP Pharmacy Regulations in Oncology (MOASC News)
  • Investigation of four health insurers for false claims to Medicare (National News)
  • Expanded indications for Revlimid and Keytruda (Industry News)

The California Medical Association (CMA), in partnership with the California Dental Association (CDA), unveiled a budget proposal to improve access to medical and dental care for the state’s 14.3 million Medi-Cal and Denti-Cal patients. For more information click here and go under California News.

Multi-Factor Authentication Required on Noridian Medicare Portal – Beginning April 1, 2017.  Beginning April 1, 2017 the Noridian Medicare Portal (NMP) will require a multi-factor authentication (MFA) process for users each time you need to log into NMP. MFA adds a second layer of security to your NMP account. For more information click here and go under Noridian News.

With an anticipated completion date of April 3, as a reminder, CMS is now phasing out the Road to 10 site. CMS has merged all up-to-date content from their Road to 10 website to the main ICD-10 site, cms.gov/ICD10, to streamline access to resources. For more information click here and go under CMS News.

If you were contacted to participate, in ASCO’s survey that will examine the specific roles and responsibilities of APPs within the cancer care delivery, ASCO urges members to complete the survey and return it as instructed by March 29. The survey should take 20 minutes or less to complete. This survey will help to better understand the contributions of advanced practice providers (APPs) working in oncology. For more information click here and go under Affiliate Association News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

March 21, 2017

Hot News!

*The California Chronic Care Coalition (CCCC) is on a mission to inform patients in California about their rights as health care consumers and they need your help! (Go to California News)

* Opposing AB 265 (Wood) (Go to California News)

*Noridian edits for code G0498 only covers Yondelis (J9999), at this time (Go to Noridian News)

*Hematology-Oncology Physician Opportunity (Go to MOASC News)

*Oncologists may be unknowingly leaving hundreds of millions in federal funding on the table (Go to CMS News)

The California Chronic Care Coalition (CCCC) is on a mission to inform patients in California about their rights as health care consumers and they need your help! Daily, patients navigate obstacles obtaining the care they need, such as: Scheduling appointments with specialists; Accessing life-saving medicines; Attaining tests and examinations. For more information click here and go under California News.

Being a co-signer to the group letter opposing AB 265 (Wood), MOASC wishes to thank you for reaching out to your patients, staff, colleagues, and affiliated hospitals.  As you know, AB 265 would ban patients in California from receiving copayment assistance programs from pharmaceutical manufacturers when a therapeutically equivalent or interchangeable brand or generic drug is available at a lower cost. For more information click here and go under California News.

Noridian edits for code G0498 only covers Yondelis (J9999), at this time. Noridian failed to include additional drugs that could be infused via pump for an extended period of time. Recognizing this error, Noridian has assured that: A new coverage article is being prepared and will be published by Noridian/JEMAC very soon. It includes several additional covered drugs—J9000 (doxorubicin). For more information click here and go under Noridian News.

Anthem Blue Cross has announced that effective May 15, Myriad Genetic Laboratories will no longer be an in-network laboratory provider. A complete list of in-network participating laboratories may be obtained online. For more information click here and go under National News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

March 14, 2017

Please find below a link to a letter, and some social media content, to oppose AB 265 (Wood) which would ban copay assistance for patients. This letter, which MOASC has signed, was delivered last week to members of the Assembly Health Committee and committee staff. An active campaign is underway to reach out to additional groups to oppose the bill. For more information click here and go under California News.

On Tuesday, March 14, 2017, in Los Angeles, the Simms/Mann-UCLA Center for Integrative Oncology is presenting, California End of Life Option Act: Hoping for the Best, Planning for the Worst and Knowing Your Options. The California End of Life Option Act is a law that went into effect in June of 2016. This new law allows some patients with terminal diagnosis to receive an aid-in-dying prescription from their physician much like in other states such as Oregon and Washington. In these states, 70-80% of patients who select this option at end of life have cancer. For more information click here and go under California News.

Noridian Medicare Portal Functionality Webinar for Part B Providers – March 23, 2017
The Noridian Provider Outreach and Education (POE) staff is hosting a Noridian Medicare Portal Functionality for Part B Providers webinar on March 23, 2017. For more information click here and go under Noridian News.

AVOID 2018 MEDICARE PAYMENT ADJUSTMENTS!  CMS has extended the deadline from February 28, 2017 to March 13, 2017 for the 2016 Quality Reporting Document Architecture (QRDA) data submission for the EHR reporting mechanism. This affects Individual eligible professionals (EPs), PQRS group practices, qualified clinical data registries (QCDRs), and qualified EHR data submission vendors (DSVs). For more information click here and go under CMS News.

ASCO is tracking legislation that would increase the legal age for the purchase of tobacco products to 21, known as “Tobacco 21,” in multiple states. The minimum age of legal access to tobacco products is set by the U.S. government at 18 years of age, however, state and local governments can set older ages. ASCO is committed to policies that will contribute to the reduced prevalence of tobacco use and prevent the occurrence of cancer and other smoking-caused diseases. For more information click here and go under Affiliate News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

March 7, 2017